Risk of tobacco-related multiple primary cancers in Bavaria, Germany

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Braisch, Ulrike ^a   Meyer, Martin ^a   Radespiel Tröger, Martin ^a  

^a Population Based Cancer Registry Bavaria   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; BRONCHUS CANCER; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GERMANY; HIGH RISK POPULATION; HUMAN; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIPLE CANCER; PATIENT CARE; PHARYNX CANCER; POPULATION RESEARCH; PRIMARY TUMOR; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; STANDARDIZED INCIDENCE RATIO; URINARY TRACT CANCER;

AGED; COHORT STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; SMOKING;

EID: 84862249553     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-250     Document Type: Article

References (39)

1. [Distribution of Cancer Diseases in Germany. Time trends of prevalences between 1990 and 2010] Verbreitung von Krebserkrankungen in Deutschland. Entwicklung der Prävalenzen zwischen 1990 und 2010. Beiträge zur Gesundheitsberichterstattung des Bundes 2010, Robert Koch-Institute, Berlin.
2. John U, Hanke M. Tobacco smoking -and alcohol drinking- attributable cancer mortality in Germany. Eur J Cancer Prev 2002, 11:11-17. 10.1097/00008469-200202000-00003, 11917204.
3. Schottenfeld D. Principles and Applications of Cancer Prevention. Cancer Epidemiology and Prevention 1996, 1404. University Press, Oxford, Schottenfeld D, Fraumeni JF.
4. Fellegi IP, Sunter AB. A Theory for Record Linkage. JASA 1969, 64:1183-1210.
5. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer 2005, 103:1457-1467. 10.1002/cncr.20910, 15712273.
6. Schoenberg BS, Myers MH. Statistical methods for studying multiple primary malignant neoplasms. Cancer 1977, 40:1892-1898. 10.1002/1097-0142(197710)40:4+<1892::AID-CNCR2820400820>3.0.CO;2-H, 907991.
7. WHO International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10) 1992, World Health Organisation, Geneva, WHO.
8. Eisinger B. Standardisierungsleitlinie für die Kodierung von urothelialen Tumoren der Harnblase. Das Manual der epidemiologischen Krebsregistrierung 2008, 87-90. Verlag, Zuckschwerdt, Hentschel S, Katalinic A, München W.
9. dos Santos Silva I. Cancer Epidemiology: Principles and Methods 1999, International Agency for Research on Cancer, Lyon.
10. Garwood F. Fiducial limits for the Poisson distribution. Biometrika 1936, 28:437-442.
11. Sahai H, Khurshid A. Confidence intervals for the mean of a poisson distribution: a review. Biom J 1993, 35:857-867.
12. SEER Standardized Incidence Ratio and Confidence Limits http://seer.cancer.gov/seerstat/WebHelp/Standardized_Incidence_Ratio_and_Confidence_Limits.htm, SEER.
13. Curtis RE, Ries LAG. Methods. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, 9-14. National Cancer Institute, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, NIH Publ. No. 05-5302, 2866968, 20142245.
14. Travis LB, Hodgson D, Allan JM, Van Leeuwen FE. Second Cancers. Cancer: Principles and Practice of Oncology 2008, 2718-2719. Lippincott Williams and Wilkins, Philadelphia, Vita VT Jr, Lawrence TS, Rosenberg SA.
15. World Medical Association (WMA) Declaration Of Helsinki: Ethical Principles for Medical Research Involving Human Subjects 2008, World Medical Association, Ferney-Voltaire, World Medical Association (WMA).
16. R Development Core Team R: A Language and Environment for Statistical Computing 2010, R Foundation for Statistical Computing, Vienna, http://www.R-project.org, R Development Core Team.
17. Wilson RT, Silverman DT, Fraumeni JF, Curtis RE. New Malignancies Following Cancer of the Urinary Tract. New Malignancies Among Cancer Survivors: SEER Cancer Registries 2006, 285-312. National Cancer Institute, NIH, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, Publ. No. 05-5302.
18. Brown LM, McCarron P, Freedman DM. New Malignancies Following Cancer of the Buccal Cavity and Pharynx. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, 15-57. National Cancer Institute, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, NIH Publ. No. 05-5302, 2866968, 20142245.
19. Stolzenberg-Solomon RZ, Fraumeni JF, Wideroff L, Albanes D, Curtis RE. New Malignancies Following Cancer of the Digestive Tract, Excluding Colorectal Cancer. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, 59-110. National Cancer Institute, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, NIH Publ. No. 05-5302, 2866968, 20142245.
20. Mysliwiec PA, Cronin KA, Schatzkin A. New Malignancies Following Cancer of the Colon, Rectum, and Anus. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, 111-144. National Cancer Institute, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, NIH Publ. No. 05-5302, 2866968, 20142245.
21. Caporaso NE, Dodd KW, Tucker MA. New Malignancies Following Cancer of the Respiratory Tract. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, 145-179. National Cancer Institute, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, NIH Publ. No. 05-5302, 2866968, 20142245.
22. SEER New Malignancies Among Cancer Survivors SEER Cancer Registries, 1973-2000. http://seer.cancer.gov/publications/mpmono/index.html, SEER.
23. Ishibe N, Curtis RE. New Malignancies Following Leukemia. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000 2006, 437-464. National Cancer Institute, Bethesda, Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr, NIH Publ. No. 05-5302, 2866968, 20142245.
24. Robert Koch Institute Association of Population-based Cancer Registries in Germany Cancer in Germany 2005/2006. Incidence and Trends 2010, Robert Koch-Institute, Berlin, Seventh, Robert Koch Institute Association of Population-based Cancer Registries in Germany.
25. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 2000, 321:323-329. 10.1136/bmj.321.7257.323, 27446, 10926586.
26. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC. Association between smoking and risk of bladder cancer among men and women. JAMA 2011, 306(7):737-745. 10.1001/jama.2011.1142, 3441175, 21846855.
27. Schwarz A. Analgesic-associated nephropathy. Klin Wochenschr 1987, 65:1-16. 10.1007/BF01785520, 3560785.
28. Chao A, Thun MJ, Jacobs EJ, Henley SJ, Rodriguez C, Calle EE. Cigarette smoking and colorectal cancer mortality in the cancer prevention study ii. J Natl Cancer Inst 2000, 92:1888-1896. 10.1093/jnci/92.23.1888, 11106680.
29. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303(3):235-241. 10.1001/jama.2009.2014, 20071471.
30. von Ruesten A, Steffen A, Floegel A, van der A DL, Masala G, Tjønneland A, Halkjaer J, Palli D, Wareham NJ, Loos RJF, Sørensen TIA, Boeing H. Trend in obesity prevalence in european adult cohort populations during follow-up since 1996 and their predictions to 2015. PLoS One 2011, 6(11):e27455. 10.1371/journal.pone.0027455, 3213129, 22102897.
31. Teppo L, Salminen E, Pukkala E. Risk of a new primary cancer among patients with lung cancer of different histological types. Eur J Cancer 2001, 37:613-619. 10.1016/S0959-8049(00)00428-7, 11290437.
32. Hölzel D, Klamert A, Schmidt M. Krebs. Häufigkeiten, Befunde und Behandlungsergebnisse: Perspektiven für die Krebsdiskussion und eine quantitative klinisch-epidemiologische Onkologie aus dem Tumorregister München 1996, Zuckerschwerdt, München.
33. Deutsche Krebsgesellschaft Kurzgefasste interdisziplinäre Leitlinien 2008. Empfehlungen zur Diagnostik und Therapie maligner Erkrankungen 2008, Zuckschwerdt, München, Sixth, Deutsche Krebsgesellschaft.
34. Pötschke-Langer M, Gleich F, Girrbach L, Schütz J, Schoppa A, Lampert T. Tabakatlas Deutschland 2009 2009, DKFZ, Deutsches Krebsforschungszentrum, Heidelberg, 29. http://www.dkfz.de/de/tabakkontrolle/download/Publikationen/sonstVeroeffentlichungen/Tabakatlas_2009.pdf.
35. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, Edison M, Ihde DC, Johnson BE. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med 1993, 119:383-390.
36. Joossens L, Raw M. The Tobacco Control Scale 2010 in Europe 2011, The Association of the European Cancer Leagues, Brussels, http://www.krebshilfe.de/fileadmin/Inhalte/Downloads/PDFs/Kampagnen/TCS_2010_Europe.pdf.
37. John U. The approach of comprehensive tobacco control in cancer prevention: elements and evidence. Eur J Cancer Prev 2002, 11:439-446. 10.1097/00008469-200210000-00006, 12394241.
38. Centers for Disease Control and Prevention Registry Eligibility Criteria http://wonder.cdc.gov/wonder/help/cancer/USCS_2002_registry_eligibility_criteria.html, Centers for Disease Control and Prevention.
39. Loeb LA, Emster VL, Warner KE, Abbotts J, Laszlo J. Smoking and lung cancer: an overview. Cancer Res 1984, 44:5940-5958.